Disclaimer

All health information news and images used on this page shared through RSS feed to MedSearch (“health data”) by the source owners who are solely responsible for its content and accuracy. MedSearch is not responsible for typographical or other errors or omissions or copyright and this lies with the owners of the source content.

Healthline

Medscape

FDA

March 19, 2025

Nalpropion Pharmaceuticals LLC – 09/22/2020

Reference #: 4674240 Product: Drugs Recipient: Recipient Name George Hampton Recipient Title Chief Executive Officer Nalpropion Pharmaceuticals LLC 10 North Park PlaceSuite 201Morristown, NJ 07960United States […]